# Recurrent Anterior Chamber Migration of Intravitreal Triamcinolone Following Scleral‐Fixated IOL Implantation

## TL;DR

This paper discusses how triamcinolone can move into the front of the eye after a specific type of lens implant, causing increased eye pressure.

## Contribution

The paper highlights a novel clinical observation about triamcinolone migration in eyes with scleral-fixated IOLs.

## Key findings

- Intravitreal triamcinolone can migrate into the anterior chamber after scleral-fixated IOL implantation.
- This migration can cause early-onset elevation of intraocular pressure (IOP).

## Abstract

In eyes with a scleral‐fixated IOL, intravitreal triamcinolone may migrate into the anterior chamber, resulting in early‐onset elevation of IOP, even at small volumes. Prompt slit lamp and gonioscopic evaluation is recommended for patients with prior vitrectomy or posterior capsule defects to ensure timely detection and treatment.